We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA GUIDANCE CLARIFIES CHANGES TO APPROVAL PROCESS
FDA GUIDANCE CLARIFIES CHANGES TO APPROVAL PROCESS
November 16, 2004
The FDA has issued a question-and-answer draft guidance that clarifies changes made by the Medicare Modernization Act (MMA) in relation to the generic-drug approval process.